Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$18.01 - $23.78 $19,468 - $25,706
-1,081 Reduced 6.4%
15,802 $341,000
Q3 2022

Nov 14, 2022

SELL
$16.32 - $26.37 $14,720 - $23,785
-902 Reduced 5.07%
16,883 $327,000
Q2 2022

Aug 15, 2022

SELL
$18.54 - $37.29 $92,978 - $187,009
-5,015 Reduced 22.0%
17,785 $353,000
Q4 2021

Feb 11, 2022

SELL
$21.19 - $31.29 $148,330 - $219,030
-7,000 Reduced 23.49%
22,800 $531,000
Q3 2021

Nov 12, 2021

SELL
$27.36 - $35.98 $103,968 - $136,724
-3,800 Reduced 11.31%
29,800 $930,000
Q2 2021

Aug 12, 2021

BUY
$28.9 - $36.87 $69,360 - $88,488
2,400 Added 7.69%
33,600 $1.18 Million
Q1 2021

May 17, 2021

SELL
$32.03 - $42.85 $12,812 - $17,140
-400 Reduced 1.27%
31,200 $1.1 Million
Q4 2020

Feb 03, 2021

BUY
$31.56 - $42.16 $160,956 - $215,015
5,100 Added 19.25%
31,600 $1.19 Million
Q3 2020

Nov 16, 2020

BUY
$23.19 - $41.61 $143,778 - $257,982
6,200 Added 30.54%
26,500 $884,000
Q2 2020

Aug 12, 2020

BUY
$14.82 - $29.92 $53,352 - $107,712
3,600 Added 21.56%
20,300 $538,000
Q1 2020

May 06, 2020

BUY
$11.67 - $27.23 $14,004 - $32,676
1,200 Added 7.74%
16,700 $273,000
Q3 2019

Nov 12, 2019

BUY
$20.0 - $31.88 $58,000 - $92,452
2,900 Added 23.02%
15,500 $310,000
Q2 2019

Aug 14, 2019

BUY
$30.67 - $37.86 $9,201 - $11,358
300 Added 2.44%
12,600 $406,000
Q1 2019

May 13, 2019

BUY
$22.22 - $32.21 $62,216 - $90,188
2,800 Added 29.47%
12,300 $396,000
Q3 2018

Nov 14, 2018

BUY
$29.29 - $36.87 $278,255 - $350,265
9,500 New
9,500 $313,000

Others Institutions Holding ALBO

About ALBIREO PHARMA, INC.


  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.